×

img Accessibility Controls

Research Projects Banner

Research Projects

Design and Synthesis of Novel Carboline-Nucleosides with Potential Viral RdRp Inhibitor Activity: Development of Broad-Spectrum Antivirals Against RNA Viruses

Implementing Organization

Principal Investigator
Dr. Subhendu Bhowmik
National Institute Of Pharmaceutical Education And Research (NIPER), Kolkata, West Bengal
CO-Principal Investigator
Dr. Anup Mazumder
National Institute Of Biomedical Genomics, West-Bengal-741251

Project Overview

Nucleoside/tide modification is a crucial area in synthetic biology and drug discovery, with modified nucleosides being used as therapeutics and biological probes against various life-threatening diseases, including viral infections. Nucleoside analogues target viral nucleic acid replication, which is crucial in regulating viral replication. However, misincorporation or mismatch of nucleotides can cause dysfunction of viral RdRps. Nucleoside-analogues exploit this misincorporation mechanism to control viral replication. The emergence of resistance against current antiviral therapeutics is a concern, and the development of newer antiviral RdRp inhibitors with improved pharmacological profiles is urgently needed. A new class of nucleoside analogues, such as carboline nucleosides, could be a compelling alternative to current antiviral nucleosides. Carboline is the basic scaffold in several drugs and natural products, and carboline heterocycles contain pyridine and indole moiety nucleobases. A novel synthetic route has been developed to construct carboline nucleosides, which have been docked against SARS-CoV-2 RdRp and shown promising results compared to Favipiravir. The researchers plan to extend the scope of the nucleosides by validating efficacy against SARS-CoV-2 RdRp and test the molecules against other RNA viruses, such as dengue virus, to develop broad-spectrum antivirals against RNA viruses.

Source

Source
Science and Engineering Research Board (SERB), DST 2022-23
Funding Organization
Quick Information
Area of Research
Pharmaceutical Sciences
Start Date
2023
End Date
2026
Status
Ongoing
Contact
sbhowmik@niperkolkata.edu.in
Output
No. of Research Paper
00
Technologies (If Any)
00
No. of PhD Produced
00
Publications
00
No. of Patents
Filed : 00
Grant : 00
arrowtop
Latest Updates
Loading…